EUVIMEDEUVIMED entdecken
Crossref

Curcumin relieves arecoline‐induced oral submucous fibrosis via inhibiting the LTBP2 / NF‐κB axis

Lin Zhang iD, Jin Tan, Yiping Liu, Mang Luo

Oral Diseases · 2024

DOI: 10.1111/odi.14656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Lin Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, Hunan Province, China. Hauptthemen laut MEDLINE: Apoptosis, Arecoline, Cell Movement, Curcumin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Submucosal fibrosis (OSF) of the oral cavity is a chronic scarring disease. Arecoline (Are) is the driving factor for the occurrence and deterioration of OSF. Curcumin plays a vital anti‐inflammatory role in Are‐induced OSF development. However, its potential pharmacological mechanism needs to be elucidated.

Methods

The relative molecular level was measured via qRT‐PCR or Western blot. MTT assay, transwell assay and flow cytometry detected cell proliferation, migration, and apoptosis. The correlation between hypoxia‐inducible factor‐1α (HIF‐1α) and LTBP2 promoter was confirmed through dual‐luciferase reporter assay. ELISA was performed to detect inflammatory cytokines levels.

Results

Curcumin alleviated Are‐induced oral mucosal fibroblast cells fibrosis by reducing oral mucosa fibroblasts viability, promoting cell apoptosis, suppressing cell migration, and down‐regulating the levels of fibrosis markers and inflammatory factors. Curcumin relieved Are‐induced OSF via inhibiting HIF‐1α. Mechanically, HIF‐1α bound to the promoter of LTBP2 to transcriptionally activated LTBP2. LTBP2 knockdown relieved Are‐induced OSF, and curcumin down‐regulated LTBP2 via inhibiting HIF‐1α to relieve Are‐induced OSF. Moreover, curcumin decreased NF‐κB signal associated proteins via inhibiting LTBP2 to relieve Are‐induced OSF.

Conclusion

Curcumin reduced the transcription level of LTBP2 by inhibiting HIF‐1α, thereby inactivating NF‐κB pathway to alleviate Are‐induced OSF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisArecolineCell MovementCurcuminHypoxia-Inducible Factor 1, alpha SubunitNF-kappa BOral Submucous FibrosisHumansCell ProliferationCells, CulturedFibroblastsMouth MucosaSignal TransductionLatent TGF-beta Binding Proteins

Stichwörter der Autor:innen

HIF‐1αLTBP2arecolinecurcuminoral submucous fibrosis

Substanzen

ArecolineCurcuminHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNF-kappa BLTBP2 protein, humanLatent TGF-beta Binding Proteins

Autor:innen und Institutionen

  • Department of Stomatology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, Hunan Province, China.
  • Hunan Changsha Maternal and Child Health Hospital, Changsha, Hunan Province, China.

ORCID-Profile: Lin Zhang

Zitieren

APA

Zhang, L., Tan, J., Liu, Y., & Luo, M. (2024). Curcumin relieves arecoline‐induced oral submucous fibrosis via inhibiting the LTBP2 / NF‐κB axis. Oral Diseases. https://doi.org/10.1111/odi.14656

Vancouver

Zhang L, Tan J, Liu Y, Luo M. Curcumin relieves arecoline‐induced oral submucous fibrosis via inhibiting the LTBP2 / NF‐κB axis. Oral Diseases. 2024. doi:10.1111/odi.14656

BibTeX
@article{Zhang2024,
  author = {Zhang, Lin and Tan, Jin and Liu, Yiping and Luo, Mang},
  title = {Curcumin relieves arecoline‐induced oral submucous fibrosis via inhibiting the LTBP2 / NF‐κB axis},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14656}
}
Kostenlos starten →